Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chronic COVID Treatment Center is a healthcare and physician-consulting organization focused on the evaluation and management of long COVID and related chronic inflammatory conditions. The organization offers laboratory-based immune profiling, telemedicine consultations, and treatment guidance for patients working with their local physicians. Its approach is built around biomarker testing, including cytokine-based assessment and the Long Hauler Index, to support diagnosis and personalized treatment selection. The center has also promoted investigational therapeutic approaches for long COVID, including CCR5 antagonist and statin-based regimens, and presents itself as active in research, publications, and physician collaboration. The website currently also markets services under the name Chronic Inflammation Treatment Center and references long COVID, Lyme disease, and ME-CFS.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chronic COVID Treatment Center.